Inhibition of eIF4E signaling by ribavirin selectively targets lung cancer and angiogenesis.
Sign Up to like & getrecommendations! Published in 2020 at "Biochemical and biophysical research communications"
DOI: 10.1016/j.bbrc.2020.05.127
Abstract: Although the introduction of immune- and targeted-therapy has improved the clinical response and outcomes, lung cancer remains a therapeutic challenge. Developing new therapeutics is necessary to improve the treatment of lung cancer. Here, we show… read more here.
Keywords: cancer; inhibition eif4e; ribavirin; lung cancer ... See more keywords